Skip to main content

Baseline Characteristics ID Risk for Recurrent Endoscopic Sinus Surgery

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 6, 2025.

By Lori Solomon HealthDay Reporter

THURSDAY, Feb. 6, 2025 -- A few baseline characteristics can predict the need for recurrent endoscopic sinus surgery (ESS) among patients with chronic rhinosinusitis with nasal polyps (CRSwNP), according to a study published online Jan. 29 in Clinical and Translational Allergy.

Sanna Toppila-Salmi, from University of Eastern Finland in Kuopio, and colleagues investigated predictors of revision ESS at one and three years in 3,506 patients with CRSwNP.

The researchers found that 15.9 percent of the patients had at least one revision surgery during the follow-up, with a median time to revision of ESS of 425 days. Higher odds of revision ESS were seen with baseline asthma (odds ratio [OR], 1.58) and antibiotic use (OR, 1.61). Increasing age was associated with lower odds of ESS revision (OR, 0.82). Compared with those who had undergone limited surgery, the highest odds of revision ESS were observed at three years for patients who had undergone extensive surgery at index (OR, 14.13). A higher cumulative dose of oral corticosteroid was seen in patients undergoing multiple ESS revisions (63 percent; median daily dose, 3.29 mg) versus patients without revisions (49 percent; median daily dose, 1.64 mg).

"The results indicate that severe chronic rhinosinusitis with nasal polyps is often associated with asthma," Toppila-Salmi said in a statement. "Patients with a severe form of the disease may benefit from additional treatments, such as biologics, if the disease cannot be managed despite repeated courses of antibiotics, oral corticosteroids, and sinus surgeries."

Several authors disclosed ties to pharmaceutical companies, including AstraZeneca, the study's sponsor.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Pediatric Magnet Ingestion Rates Still High

THURSDAY, May 22, 2025 -- Global pediatric magnet ingestion rates remain high and incidence has increased, despite the implementation of national policies, according to a review...

Similar Survival Seen With Simple Versus Radical Hysterectomy for Cervical Cancer

WEDNESDAY, May 21, 2025 -- For patients with low-risk cervical cancer, survival is similar following simple hysterectomy (SH) versus modified radical hysterectomy (MRH) or radical...

Stereotactic Body Radiotherapy Feasible After Radical Prostatectomy

TUESDAY, May 20, 2025 -- Post-radical prostatectomy (post-RP) stereotactic body radiotherapy (SBRT) is well tolerated, with patient-reported outcomes (PROs) comparable to those...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.